# Costus (Saussurea costus)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/costus
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-03-19
**Evidence Score:** 4 / 10
**Category:** Ayurveda
**Also Known As:** Saussurea costus, Saussurea lappa, Costus root, Kuth, Qust, Pachak, Upleta, Indian costus

## Overview

Costus (Saussurea costus) contains bioactive compounds including costunolide and dehydrocostuslactone that demonstrate [anti-inflammatory](/ingredients/condition/inflammation) properties. Animal studies show it reduces inflammatory cytokines TNF-α, IL-1β, IL-8, and IL-18 in colitis models.

## Health Benefits

• [Anti-inflammatory](/ingredients/condition/inflammation) effects: Animal studies show reduced TNF-α, IL-1β, IL-8, and IL-18 levels in colitis models (PMID: 39936162) - preliminary evidence only
• Gut microbiota modulation: Mouse studies demonstrate altered [microbiome](/ingredients/condition/gut-health) composition in ulcerative colitis models - preclinical evidence
• Potential anticancer activity: In vitro studies show costunolide induces apoptosis in HL-60 leukemia cells via ROS-mediated pathways - laboratory evidence only
• [Thyroid](/ingredients/condition/hormonal) support: Animal models suggest protective effects against thyroid dysfunction - no human data available
• Traditional digestive aid: Historical use in Ayurveda for digestive disorders - no clinical validation

## Mechanism of Action

Costus root contains sesquiterpene lactones including costunolide and dehydrocostuslactone that inhibit [pro-inflammatory cytokine](/ingredients/condition/inflammation) production. These compounds reduce TNF-α, IL-1β, IL-8, and IL-18 levels through modulation of inflammatory pathways. The root also influences [gut microbiome](/ingredients/condition/gut-health) composition, potentially through prebiotic effects on beneficial bacteria.

## Clinical Summary

Current evidence for costus is limited to preclinical animal studies, primarily in mouse models of ulcerative colitis. One study (PMID: 39936162) demonstrated significant reductions in [inflammatory](/ingredients/condition/inflammation) markers including TNF-α, IL-1β, IL-8, and IL-18 levels. Mouse studies also show alterations in [gut microbiome](/ingredients/condition/gut-health) composition, but sample sizes and study durations remain limited. No human clinical trials have been conducted to validate these preliminary findings.

## Nutritional Profile

Costus root (Saussurea costus) is primarily valued for its bioactive phytochemicals rather than conventional macronutrient content. Key bioactive compounds include: Sesquiterpene lactones: costunolide (major active constituent, ~0.3–1.2% of dry root weight) and dehydrocostus lactone (~0.2–0.8% dry weight), which are the principal [anti-inflammatory](/ingredients/condition/inflammation) and anticancer agents. Essential oils: 1–3% total volatile oil content, composed primarily of costol (~5–10% of oil fraction), α-costic acid, β-costic acid, and cyperene. Alkaloids: saussurine (trace amounts, <0.1% dry weight). Sterols: β-sitosterol and stigmasterol present in root lipid fraction. Lignans: lappaol and related compounds detected in minor quantities. Inulin-type fructans: reported as a carbohydrate storage component (~15–20% dry weight), contributing to [prebiotic](/ingredients/condition/gut-health)-like properties relevant to gut microbiota modulation. Crude fiber: estimated 10–15% dry weight based on related Asteraceae roots. Protein content is modest, approximately 5–8% dry weight with limited characterization of amino acid profile. Mineral content includes iron, zinc, and calcium at levels typical of dried medicinal roots (iron ~12–18 mg/100g dry weight reported in related analyses). Bioavailability notes: Costunolide and dehydrocostus lactone demonstrate moderate oral bioavailability; sesquiterpene lactones are lipophilic and absorption is enhanced with fat-containing meals. Significant first-pass hepatic [metabolism](/ingredients/condition/weight-management) is documented for costunolide. The intact root matrix likely slows release compared to isolated extracts. Standardized extracts are typically normalized to costunolide content. Note: Comprehensive nutritional profiling data (precise vitamin content, complete amino acid profile) remains limited in published literature; most analytical data derives from phytochemical isolation studies rather than full proximate analysis.

## Dosage & Preparation

No clinically studied dosage ranges for humans have been established. Animal studies used unspecified doses of root extracts without standardization details or human dose equivalents. Consult a healthcare provider before starting any new supplement.

## Safety & Drug Interactions

Safety data for costus supplementation is limited due to lack of human clinical trials. Traditional use suggests general tolerability, but potential side effects, optimal dosing, and long-term safety remain undetermined. No specific drug interactions have been documented, though theoretical interactions with [anti-inflammatory](/ingredients/condition/inflammation) medications may exist. Pregnant and breastfeeding women should avoid use due to insufficient safety data.

## Scientific Research

No human clinical trials, RCTs, or meta-analyses were identified for Saussurea costus. Evidence is limited to preclinical animal studies, including a DSS-induced ulcerative colitis mouse model showing [anti-inflammatory](/ingredients/condition/inflammation) effects (PMID: 39936162), and in vitro cancer cell line studies demonstrating apoptotic mechanisms.

## Historical & Cultural Context

Saussurea costus has been used for centuries in Ayurvedic and Unani traditional medicine systems for treating asthma, digestive disorders, skin conditions, and diabetes. Ethnobotanical surveys in India identify it as a potent traditional remedy for [inflammation](/ingredients/condition/inflammation) and hypoglycemic effects.

## Synergistic Combinations

Turmeric, Boswellia, Ginger, Triphala, Ashwagandha

## Frequently Asked Questions

### What compounds in costus root are responsible for anti-inflammatory effects?

The primary bioactive compounds are sesquiterpene lactones, specifically costunolide and dehydrocostuslactone. These compounds have been shown to reduce inflammatory cytokines TNF-α, IL-1β, IL-8, and IL-18 in animal studies.

### What is the recommended dosage for costus supplements?

No standardized human dosage has been established for costus supplements due to lack of clinical trials. Traditional Ayurvedic preparations typically use 1-3 grams of root powder daily, but safety and efficacy at these doses remain unverified.

### Can costus help with inflammatory bowel disease?

Animal studies show promising anti-inflammatory effects in colitis models, with reduced inflammatory markers and improved gut microbiome composition. However, no human trials have been conducted, so effectiveness for IBD in humans remains unproven.

### Is costus safe to take with other medications?

Safety interactions are unknown due to limited research. Theoretical interactions may exist with anti-inflammatory drugs or immunosuppressants given costus's anti-inflammatory properties, but no specific interactions have been documented.

### How long does it take for costus to show anti-inflammatory effects?

Animal studies typically show inflammatory marker reductions within days to weeks of treatment. However, human response times are unknown, and individual results may vary significantly based on dosage, formulation, and underlying health conditions.

### What is the difference between costus root extract and whole costus root powder?

Costus root extract is a concentrated form that isolates active compounds like costunolide and dehydrocostus lactone, potentially offering higher potency per dose compared to whole root powder. Whole root powder contains the complete plant matrix with additional phytochemicals that may work synergistically, though at lower concentrations of individual active compounds. Extract forms typically offer more standardized dosing, while whole root provides a broader spectrum of plant constituents with less processing.

### Is costus safe for children and elderly populations?

Safety data specifically for children and elderly individuals is limited, as most research has focused on adult animal models and in vitro studies rather than human clinical trials. Costus has been used traditionally in Ayurvedic and traditional Chinese medicine across various age groups, but pediatric and geriatric dosing recommendations lack robust clinical evidence. Individuals in these populations should consult a healthcare provider before use, particularly those taking medications or with compromised kidney or liver function.

### How strong is the current scientific evidence supporting costus for gastrointestinal health?

Current evidence is preliminary and limited to animal studies and in vitro research, with no completed human clinical trials published on costus for gastrointestinal conditions. Mouse models show promise for modulating inflammation markers in colitis, but these findings cannot be directly extrapolated to human efficacy or safety. More rigorous randomized controlled trials in humans are needed before costus can be recommended as an evidence-based treatment for digestive disorders.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*